Orexigen Therapeutics, Inc. – NASDAQ:OREX

Financial Health
0
1
2
3
4
5
6
7
8
9

Orexigen Therapeutics key metrics

Market Cap
N/A
Enterprise value
N/A
P/E
N/A
EV/Sales
N/A
EV/EBITDA
N/A
Price/Sales
N/A
Price/Book
N/A
PEG ratio
N/A
EPS
-1.61
Revenue
75.28M
EBITDA
-11.23M
Income
-24.52M
Revenue Q/Q
169.96%
Revenue Y/Y
204.09%
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
-14.92%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Orexigen Therapeutics stock price history

Orexigen Therapeutics stock forecast

Orexigen Therapeutics financial statements

Orexigen Therapeutics, Inc. (NASDAQ:OREX): Profit margin
Dec 2016 13.88M -24.52M -176.65%
Mar 2017 19.14M -69.08M -360.86%
Jun 2017 23.35M -30.51M -130.66%
Sep 2017 18.90M 99.60M 526.93%
0%
Yield TTM
Orexigen Therapeutics, Inc. (NASDAQ:OREX): Payout ratio
Payout ratio 0%
Orexigen Therapeutics, Inc. (NASDAQ:OREX): Dividend Yield
2013
2014
2015 0.22%
2016 75.6%
Orexigen Therapeutics, Inc. (NASDAQ:OREX): Debt to assets
Dec 2016 304589000 247.54M 81.27%
Mar 2017 236383000 244.23M 103.32%
Jun 2017 189999000 232.02M 122.12%
Sep 2017 183747000 246.11M 133.94%
Orexigen Therapeutics, Inc. (NASDAQ:OREX): Cash Flow
Dec 2016 -33.70M 61.88M -9.92M
Mar 2017 -49.93M 48.08M -13.97M
Jun 2017 -40.12M 38K 47K
Sep 2017 -16.28M 24.99M 90K

Orexigen Therapeutics other data

  • When is Orexigen Therapeutics's next earnings date?

    Unfortunately, Orexigen Therapeutics's (OREX) next earnings date is currently unknown.

  • Does Orexigen Therapeutics pay dividends?

    No, Orexigen Therapeutics does not pay dividends.

  • What is Orexigen Therapeutics's stock symbol?

    Orexigen Therapeutics, Inc. is traded on the NASDAQ under the ticker symbol "OREX".

  • How do i buy shares of Orexigen Therapeutics?

    Shares of Orexigen Therapeutics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • When Orexigen Therapeutics went public?

    Orexigen Therapeutics, Inc. is publicly traded company for more then 18 years since IPO on 26 Apr 2007.

Orexigen Therapeutics company profile:

Orexigen Therapeutics, Inc.

Exchange:

NASDAQ

Full time employees:

0

Industry:

Sector:


,

CIK: 0001382911
:
: